Data as of 3:59pm ET
| +0.032 / +3.76%|
The 2 analysts offering 12-month price forecasts for StemCells Inc have a median target of 3.75, with a high estimate of 5.00 and a low estimate of 2.50. The median estimate represents a +324.21% increase from the last price of 0.88.
The current consensus among 2 polled investment analysts is to Buy stock in StemCells Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.